ArticleTherapeutic advances in medical oncology2025

Cost-effectiveness analysis of belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma in the United States and China.

Baolong Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.